CD38 and Miyoshi myopathy: In addition, several small protein derived analogs including nanobodies and single domain antibodies have been developed and evaluated in preclinical models of MM.[22, 43, 44] Most of those agents provide CD38 specific images within few hours of radiotracer injection.